RESUMO
Non-tuberculous mycobacterial infection (NTM) is rare in healthy children, with lymphadenitis being the most common presentation. Immunocompromised populations are known to be at high risk, but the clinical picture of NTM infection in pediatric hematology/oncology patients is unclear. In this nationwide retrospective analysis of patients under the age of 40 treated in Japanese pediatric hematology/oncology departments who developed NTM infection between January 2010 and December 2020, 36 patients (21 patients with hematopoietic stem cell transplantation (HSCT) and 15 nontransplant patients) were identified. Post-transplant patients were infected with NTM at 24 sites, including the lungs (n = 12), skin and soft tissues (n = 6), bloodstream (n = 4), and others (n = 2). Nine of twelve patients with pulmonary NTM infection had a history of pulmonary graft-versus-host disease (GVHD), and rapid-growing mycobacteria (RGM) were isolated from five of them. In nontransplant patients, the primary diseases were acute lymphoblastic leukemia (ALL; n = 5), inborn errors of immunity (IEI; n = 6), and others (n = 4). All cases of ALL had bloodstream infections with RGM, whereas all cases of IEI were infected with slow-growing mycobacteria (SGM). In summary, three typical clinical scenarios for pediatric hematology/oncology patients have been established: RGM-induced pulmonary disease in patients with pulmonary GVHD, RGM bloodstream infection in patients with ALL, and SGM infection in patients with IEI. Our findings suggest that NTM must be regarded as a pathogen for infections in these high-risk patients, especially those with pulmonary GVHD, who may require active screening for NTM.
RESUMO
Responsive liquid marbles (LMs), which can change their shape, stability, and motion by the application of stimuli, attract a growing interest due to their wide range of applications. Our approach to design photo- and thermoresponsive LMs is based on the use of micrometer-sized fatty acid (FA) particles as phase change material covered with polypyrrole (PPy) overlayers with photothermal property. The core-shell particles were synthesized by aqueous chemical oxidative seeded dispersion polymerization. First, we investigated the effect of the alkyl chain length of FA on the resulting FA/PPy core-shell particles by characterizing their size and its distribution, shape, morphology, chemical composition, and photothermal behavior. Then LMs were fabricated by rolling water droplets on the dried FA/PPy particle powder bed and their light and temperature dual stimuli-responsive nature was studied as a function of the FA alkyl chain length. For all FAs studied, LMs disrupted in a domino manner by light irradiation as the first trigger: the temperature of the FA/PPy particles on the LM surface increased by light irradiation, followed by phase change of FA core of the particles from solid to liquid, resulting in disruption of the LM and release of the encapsulated water. The disruption time was closely correlated to the melting point of FA linked to the alkyl chain length and light irradiation power, and it could be controlled and tuned easily between quasi instantaneous and approximately 10 s. Finally, we showed potential applications of the LMs as a carrier for controlled delivery and release of substances and a sensor.
Assuntos
Polímeros , Pirróis , Polímeros/química , Pirróis/química , Ácidos Graxos , Água/químicaRESUMO
Various treatments have been used to treat chronic immune thrombocytopenic purpura in children; however, none of it has been established as the standard of care. The administration of thrombopoietin receptor agonists (TPO-RAs) has been approved as a new treatment option in Japan. In this case series, TPO-RAs were administered to 16 patients (eltrombopag, n=9; romiplostim, n=7). Excluding the data of two patients who underwent splenectomy immediately after starting treatment with these medicines, platelet counts increased to ≥50,000/µl in seven patients. The adverse events recorded were grade 2 liver dysfunction (n=1), according to the common terminology criteria for adverse events version 4, and myelofibrosis (classified as MF1 or mild reticulin fibrosis), as observed on bone marrow biopsy (n=2). We continued the administration of TPO-RAs at the same dose in these patients because the complications they experienced were mild. The risk of adverse events associated with long-term use of TPO-RAs in this pediatric population remains unclear, and a prospective evaluation is needed.
Assuntos
Púrpura Trombocitopênica Idiopática , Receptores de Trombopoetina/agonistas , Criança , Humanos , Japão , Púrpura Trombocitopênica Idiopática/tratamento farmacológicoRESUMO
Acute promyelocytic leukemia (APL) is rare in patients with Down syndrome (DS). Cytotoxic chemotherapy combined with all-trans retinoic acid (ATRA) has been a standard treatment for APL, but is potentially intolerable for DS patients because of their vulnerability to cytotoxic agents. We report here a case of a 10-year-old girl with DS and APL successfully treated with a combination of ATRA and arsenic trioxide, a therapy emerging as a new standard for APL. She achieved molecular remission and completed the therapy without significant toxicities. ATRA/arsenic trioxide combination therapy would be a preferable option for DS patients with APL.
Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Síndrome de Down/tratamento farmacológico , Leucemia Promielocítica Aguda/tratamento farmacológico , Trióxido de Arsênio/administração & dosagem , Criança , Feminino , Humanos , Tretinoína/administração & dosagemRESUMO
Gilteritinib is an FMS-like tyrosine kinase 3 (FLT3) inhibitor that has shown efficacy in patients with refractory or recurrent adult acute myeloid leukemia (AML) with FLT3 mutations. However, there are limited data for pediatric patients treated with this drug. Herein, we report the clinical courses of two children with FLT3-mutated recurrent AML who received gilteritinib. Case 1: An 11-year-old boy with secondary relapsed AML presented with an FLT3 internal tandem duplication (ITD) since the first recurrence. One week after gilteritinib initiation, blasts, which had comprised 90% of the white blood cells before treatment, almost disappeared from the peripheral blood without tumor lysis syndrome. The patient developed multiple adverse effects and died from the disease 2.5 months after gilteritinib initiation. Case 2: A 12-year-old girl diagnosed with AML was positive for FLT3 ITD. She received gilteritinib during her first relapse post-stem cell transplantation. After the drug was administered, the recipient cell counts increased, as determined by molecular tests (i.e., FISH), whereas microscopically, there was a complete response for 5 months with good performance status. Gilteritinib treatment in children with FLT3-mutated recurrent AML is feasible and effective. As a patient experienced several adverse effects with gilteritinib treatment, clinical trials are required to determine the appropriate pediatric dose of this medication.
Assuntos
Compostos de Anilina/uso terapêutico , Leucemia Mieloide Aguda , Pirazinas/uso terapêutico , Criança , Feminino , Humanos , Leucemia Mieloide Aguda/tratamento farmacológico , Masculino , Mutação , Recidiva , Tirosina Quinase 3 Semelhante a fmsRESUMO
ABSTRACT: Transient abnormal myelopoiesis (TAM) occurs in 10% of neonates with Down syndrome (DS). Although most patients show spontaneous resolution of TAM, early death occurs in â¼20% of cases. Therefore, new biomarkers are needed to predict early death and determine therapeutic interventions. This study aimed to determine the association between clinical characteristics and cytokine levels in patients with TAM. A total of 128 patients with DS with TAM enrolled in the TAM-10 study conducted by the Japanese Pediatric Leukemia/Lymphoma Study Group were included in this study. Five cytokine levels (interleukin-1b [IL-1b], IL-1 receptor agonist, IL-6, IL-8, and IL-13) were significantly higher in patients with early death than in those with nonearly death. Cumulative incidence rates (CIRs) of early death were significantly associated with high levels of the 5 cytokines. Based on unsupervised consensus clustering, patients were classified into 3 cytokine groups: hot-1 (n = 37), hot-2 (n = 42), and cold (n = 49). The CIR of early death was significantly different between the cytokine groups (hot-1/2, n = 79; cold, n = 49; hot-1/2 CIR, 16.5% [95% confidence interval (CI), 7.9-24.2]; cold CIR, 2.0% [95% CI, 0.0-5.9]; P = .013). Furthermore, cytokine groups (hot-1/2 vs cold) were independent poor prognostic factors in the multivariable analysis for early death (hazard ratio, 15.53; 95% CI, 1.434-168.3; P = .024). These results provide valuable information that cytokine level measurement was useful in predicting early death in patients with TAM and might help to determine the need for therapeutic interventions. This trial was registered at UMIN Clinical Trials Registry as #UMIN000005418.
Assuntos
Citocinas , Síndrome de Down , Reação Leucemoide , Humanos , Citocinas/sangue , Masculino , Feminino , Reação Leucemoide/diagnóstico , Reação Leucemoide/sangue , Síndrome de Down/mortalidade , Síndrome de Down/complicações , Lactente , Pré-Escolar , Biomarcadores , Recém-Nascido , Criança , Mielopoese , PrognósticoRESUMO
Allogeneic hematopoietic cell transplantation (HCT) is a crucial treatment for various diseases, including hematological malignancies, solid tumors, and genetic disorders. Despite its curative potential, HCT is associated with severe complications, notably infections, graft-versus-host disease, and organ damage. Infections, particularly bloodstream infections (BSIs), pose a significant threat in the initial weeks post-HCT, necessitating effective management strategies. This retrospective study aimed to clarify the incidence, pathogens, and risk factors associated with BSI within the first 30 days after allogeneic HCT in children/adolescents and young adults (AYAs). The study included 115 patients aged <31 years who underwent 121 allogeneic HCTs at the Department of Pediatrics, Nagoya University Hospital between January 1, 2018, and March 31, 2022. Data encompassed demographic characteristics, HCT details, and BSI information. Overall, 27 of 121 patients developed BSI with the cumulative incidence of 23.5% (95% confidence intervals [CI]: 17.0%-30.6%) at 30 days after HCT. The median onset time of BSI was 7 (range, 4-26 days) after HCT. Gram-positive bacteria accounted for 89% of pathogens isolated from blood cultures, with Streptococcus mitis/oralis being the most common. In multivariable analysis, tandem HCT (subdistribution hazard ratio [SHR]: 5.67, 95% CI: 2.74-11.7, p < 0.001) and peripherally inserted central catheters (SHR: 2.96, 95% CI: 1.34-6.55, p = 0.007) were identified as independent risk factors for BSI. In patients receiving tandem HCT, the pathogens isolated from blood cultures were all gram-positive bacteria, with Streptococcus mitis/oralis accounting for up to 67% of the isolated pathogens. Tandem HCT and PICCs were identified as independent risk factors for BSI after allogeneic HCT in children/AYAs. The pathogens were commonly gram-positive, and Streptococcus mitis/oralis is important in patients who received tandem HCT. These data can provide valuable information for future studies to consider effective interventions to reduce the risk of BSI in high-risk patients.
Assuntos
Transplante de Células-Tronco Hematopoéticas , Humanos , Transplante de Células-Tronco Hematopoéticas/efeitos adversos , Masculino , Feminino , Criança , Adolescente , Fatores de Risco , Adulto Jovem , Adulto , Pré-Escolar , Estudos Retrospectivos , Lactente , Transplante Homólogo/efeitos adversos , Incidência , Bacteriemia/epidemiologia , Bacteriemia/etiologia , Bacteriemia/microbiologiaRESUMO
HYPOTHESIS: Gallium-based room-temperature liquid metals (LMs) have unique physicochemical properties; however, their high surface tension, low flowability, and high corrosiveness to other materials limit their advanced processing (including precise shaping) and application. Consequently, LM-rich free-flowing powders, named "dry LMs" that offer the inherent advantages of dry powders, should play a critical role in expanding the application scope of LMs. EXPERIMENTS: A general method of preparing silica-nanoparticle-stabilized LMs in the form of LM-rich powders (>95 wt% LM) is developed. FINDINGS: Dry LMs can be simply prepared by mixing LMs with silica nanoparticles in a planetary centrifugal mixer in the absence of solvents. As a sustainable dry-process route alternative to wet-process routes, this ecofriendly and simple method of dry LM fabrication has several advantages, e.g., high throughput, scalability, and low toxicity owing to the lack of organic dispersion agents and milling media. Moreover, the unique photothermal properties of dry LMs are used for photothermal electric power generation. Thus, dry LMs not only pave the way for the use of LMs in powder form but also provide a new opportunity for expanding their application scope in energy conversion systems.
RESUMO
Acute graft-versus-host disease (aGVHD) is a challenging complication of allogeneic hematopoietic stem cell transplantation, and alternative therapies for patients showing inadequate response to steroids are limited. Vedolizumab, an anti-α4ß7 integrin antibody widely used for treating inflammatory bowel diseases, has recently been studied in adult patients with steroid-refractory intestinal aGVHD. However, few studies have examined its safety and effectiveness in pediatric patients with intestinal aGVHD. We report the case of a male patient with intestinal late-onset aGVHD treated with vedolizumab. He underwent allogeneic cord blood transplantation for warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome and developed intestinal late-onset aGVHD 31 months after transplantation. The patient was refractory to steroids; however, vedolizumab was initiated 43 months after transplantation (at the age of 7 years) and the symptoms of intestinal aGVHD were alleviated. Additionally, favorable endoscopic findings were observed, such as reduction of erosion and regenerative epithelial growth. We also evaluated the efficacy of vedolizumab in 10 patients with intestinal aGVHD (9 from the literature review and the present case). Six patients (60%) showed an objective response to vedolizumab. No serious adverse events were observed in any patients. Vedolizumab is a potential treatment option for steroid-refractory intestinal aGVHD in pediatric patients.
Assuntos
Doença Enxerto-Hospedeiro , Transplante de Células-Tronco Hematopoéticas , Adulto , Humanos , Masculino , Criança , Anticorpos Monoclonais Humanizados/uso terapêutico , Transplante de Células-Tronco Hematopoéticas/efeitos adversos , Doença Enxerto-Hospedeiro/tratamento farmacológico , Doença Enxerto-Hospedeiro/etiologia , Esteroides , Doença AgudaRESUMO
Pituitary organoids are promising graft sources for transplantation in treatment of hypopituitarism. Building on development of self-organizing culture to generate pituitary-hypothalamic organoids (PHOs) using human pluripotent stem cells (hPSCs), we established techniques to generate PHOs using feeder-free hPSCs and to purify pituitary cells. The PHOs were uniformly and reliably generated through preconditioning of undifferentiated hPSCs and modulation of Wnt and TGF-ß signaling after differentiation. Cell sorting using EpCAM, a pituitary cell-surface marker, successfully purified pituitary cells, reducing off-target cell numbers. EpCAM-expressing purified pituitary cells reaggregated to form three-dimensional pituitary spheres (3D-pituitaries). These exhibited high adrenocorticotropic hormone (ACTH) secretory capacity and responded to both positive and negative regulators. When transplanted into hypopituitary mice, the 3D-pituitaries engrafted, improved ACTH levels, and responded to in vivo stimuli. This method of generating purified pituitary tissue opens new avenues of research for pituitary regenerative medicine.
Assuntos
Hormônio Adrenocorticotrópico , Células-Tronco Pluripotentes , Camundongos , Animais , Humanos , Molécula de Adesão da Célula Epitelial , Técnicas de Cultura de Células/métodos , Diferenciação CelularRESUMO
Western countries that were first to administer the COVID-19 vaccination report cases of vaccine-induced axillary lymphadenitis with high FDG uptake. However, no such findings have been reported from any Asian countries. We report here a confusing case of a 31-year-old female cancer survivor with high FDG uptake in her axillary lymph nodes, suggesting recurrence, following mRNA COVID-19 vaccination. Although the value of SUVmax was elevated (12.7), additional imaging revealed that her lymphatic lesions were benign, and they resolved spontaneously. This case of a strong immune reaction to COVID-19 vaccination in regional lymph nodes is the first reported in a Japanese patient. We should be aware of this new mimic and optimize diagnostic imaging methods accordingly in the era of COVID-19.
Assuntos
COVID-19 , Sobreviventes de Câncer , Linfadenite , Adulto , Vacinas contra COVID-19 , Feminino , Fluordesoxiglucose F18 , Humanos , Linfadenite/induzido quimicamente , Linfadenite/diagnóstico , Metástase Linfática , Recidiva Local de Neoplasia , RNA Mensageiro , SARS-CoV-2RESUMO
In this study, we report on the fabrication of photo/thermo dual stimulus-responsive liquid marbles (LMs) that can be disrupted by light irradiation and/or heating. To stabilize the LMs, we synthesized micrometer-sized stearic acid (SA) particles coated with overlayers of polypyrrole (PPy) by aqueous chemical oxidative seeded dispersion polymerization. The SA/PPy core-shell particles could adsorb at the air-water interface to stabilize LMs by rolling water droplets on the particle powder bed. The presence of SA, known as a phase-change material, which undergoes a transition from solid to liquid by heating, and PPy, which can transduce light to heat, gives rise to the photo and thermo dual stimulus-responsive characters of the LMs. The disruption of the LMs could be induced in a cascade manner: light irradiation on the LM induced a temperature increase, followed by melting of the SA component on the LM surface, leading to its disruption and release of the inner water. The disruption time is linked to the PPy loading and light irradiation power, and it can be tuned from quasi-instantaneous to a few tens of seconds. The melting of SA due to a light-induced phase change from the solid to liquid state is a new mechanism to trigger the disruption of LMs. We finally demonstrated two applications of the LMs as a light-responsive microreactor and a sensor.
RESUMO
It is widely accepted that adipose-derived regenerative cells (ADRCs) can differentiate into mesodermal lineage cells. However, reprogramming adult ADRCs into mature cardiomyocytes is challenging. We investigated the induction of myocardial differentiation in ADRCs via direct reprogramming using lentiviral gene transfer. First, we identified candidate transcriptional factors by performing RNA sequencing and ultimately confirmed that the combination of six unique factors (Baf60c, Gata4, Gata6, Klf15, Mef2a, and Myocd) could efficiently express enhanced green fluorescent protein (GFP) in ADRCs isolated from adult alpha-myosin heavy chain promoter-driven GFP transgenic mice. The GFP-positive ADRCs induced by six factors (6F-ADRCs) expressed multiple cardiac genes and revealed cardiac differentiation in bioinformatic analysis. Moreover, injection of 6F-ADRCs into acute myocardial infarcted tissues in vivo resulted in the improvement of survival rate, fractional shortening, and reduction of infarction scar area. This study provides an alternative method for direct reprogramming of adult ADRCs into cardiomyocytes.
RESUMO
Recently, whole-exome sequencing (WES) has been used for genetic diagnoses of patients who remain otherwise undiagnosed. WES was performed in 177 Japanese patients with undiagnosed conditions who were referred to the Tokai regional branch of the Initiative on Rare and Undiagnosed Diseases (IRUD) (TOKAI-IRUD). This study included only patients who had not previously received genome-wide testing. Review meetings with specialists in various medical fields were held to evaluate the genetic diagnosis in each case, which was based on the guidelines of the American College of Medical Genetics and Genomics. WES identified diagnostic single-nucleotide variants in 66 patients and copy number variants (CNVs) in 11 patients. Additionally, a patient was diagnosed with Angelman syndrome with a complex clinical phenotype upon detection of a paternally derived uniparental disomy (UPD) [upd(15)pat] wherein the patient carried a homozygous DUOX2 p.E520D variant in the UPD region. Functional analysis confirmed that this DUOX2 variant was a loss-of-function missense substitution and the primary cause of congenital hypothyroidism. A significantly higher proportion of genetic diagnoses was achieved compared to previous reports (44%, 78/177 vs. 24-35%, respectively), probably due to detailed discussions and the higher rate of CNV detection.
Assuntos
Exoma , Doenças não Diagnosticadas , Variações do Número de Cópias de DNA , Oxidases Duais , Homozigoto , Humanos , Doenças Raras , Dissomia Uniparental , Sequenciamento do ExomaRESUMO
Emicizumab reduces bleeding in patients with hemophilia A and inhibitors (PwHA-I). Coagulation potential during the perioperative period in emicizumab-treated PwHA-I undergoing surgery remains to be evaluated. We describe a 14-year-old boy with HA-I receiving emicizumab prophylaxis who experienced arthroscopic synovectomy. He was treated with a bolus infusion of recombinant factor VIIa (rFVIIa; 80 µg/kg) immediately before surgery, and treatment continued at the same dose every 3 h on day 1, every 4 h on day 2, and every 6 h on day 3. Treatment with rFVIIa was discontinued on day 4. No perioperative bleeding or thrombotic events were observed. Coagulation potential throughout the perioperative period was retrospectively assessed with an easy-to-use clot waveform analysis (CWA). Measurements from CWA returned to within or near the normal range, suggesting successful hemostatic management. Coagulation potentials assessed by CWA showed a significant correspondence with those from a thrombin generation assay (TGA) that is already in use. CWA and TGA could both provide useful data for assessing coagulation potential in the perioperative hemostatic management of emicizumab-treated PwHA-I.
Assuntos
Anticorpos Biespecíficos/administração & dosagem , Anticorpos Monoclonais Humanizados/administração & dosagem , Inibidores dos Fatores de Coagulação Sanguínea/sangue , Fator VIIa/administração & dosagem , Hemofilia A , Hemostasia , Sinovectomia , Adolescente , Testes de Coagulação Sanguínea , Hemofilia A/sangue , Hemofilia A/terapia , Humanos , Masculino , Proteínas Recombinantes/administração & dosagemRESUMO
Dormant compound buds of grapevines adapt to subfreezing temperatures through a freezing avoidance mechanism. One still-unclear question, however, is whether supercooled water in primordial cells of dormant grape buds are partially dehydrated under subfreezing temperatures. In this study, we used differential thermal analysis (DTA) and cryo-scanning electron microscopy (cryo-SEM) to look for partial dehydration of primordial cells of the freezing-resistant interspecific hybrid cultivar 'Yamasachi'. According to DTA, the freezing temperature of supercooled water in primary buds was not significantly affected by cooling rates between 2 and 5 °C/h; however, maintaining the bud temperature at -15 °C for 12 h followed by cooling at a rate of 5 °C/h depressed the freezing temperature. As revealed by cryo-SEM observation, many wrinkles were present on inner surfaces of walls and outer surfaces of plasma membranes of leaf primordial cells in dormant buds frozen to -15 °C. These results suggest the existence of partial dehydration in dormant-bud primordial cells under subfreezing temperatures. The apparent absence of extracellular ice crystals in bud primordial tissues under subfreezing temperatures suggests that Yamasachi dormant buds adapt to subfreezing temperatures by extraorgan freezing. When we coated primary buds with silicone oil to inhibit freeze dehydration of primordial cells, the freezing temperature of buds was slightly but significantly increased. This result suggests that the partial dehydration of cells promotes bud supercooling capability and has an important role in the freezing adaptation mechanism of grapevines.
Assuntos
Vitis/fisiologia , Aclimatação , Quimera , Temperatura Baixa , Desidratação , Congelamento , Microscopia Eletrônica de Varredura , Folhas de Planta/fisiologia , Folhas de Planta/ultraestrutura , Vitis/ultraestrutura , Água/fisiologiaRESUMO
Severe protein C (PC) deficiency leads to purpura fulminans and stroke in newborns. However, the clinical impact of plasma PC activity on the development of neonatal cerebral disease remains elusive. We report a case of hemorrhagic stroke associated with neonatal asphyxia and severe PC deficiency. Plasma PC and protein S activity 7 days after birth was 12% and 43%, respectively. No PROC mutation was found. PC levels did not exceed 20% until 2 months of age, even in the absence of consumption coagulopathy or vitamin K deficiency. Neither thromboembolic nor hemorrhagic events occurred during the infusion of activated PC concentrate (twice weekly, up to 68 days after birth). The PC activity levels gradually increased to the standard value for age by 9 months of age. The present case showed that neonatal PC deficiency without a PROC mutation caused an intracranial hemorrhage before a slow increase in PC activity.